Influence Of Growth Hormone Replacement On Neurological And ...

Trang chủ » Hgh Baixo » Influence Of Growth Hormone Replacement On Neurological And ...

Có thể bạn quan tâm

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract in English, Portuguese

The height response to the use of growth hormone in short height cases has already been confirmed in the literature. The influence of the insulin-like growth factor 1 (GH-IGF1) axis components on development, function, regeneration, neuroprotection, cognition, and motor functions has been evaluated in experimental studies and in adults with central nervous system lesions. However, there is still little research on the clinical impact of hormone replacement on neurological and psychomotor development. This report presents the case of a patient with excellent weight-height recovery and, even more surprisingly, neurological and psychomotor development in response to use of growth hormone. The result strengthens the correlation between experimental and clinical findings related to cerebral plasticity response to growth hormone in children. A preterm male patient with multiple health problems during the neonatal and young infancy period, who for six years presented with a relevant deficit in growth, bone maturation, and neurological and psychomotor development. At six years of age, he had low stature (z-score -6.89), low growth rate, and low weight (z-score -7.91). He was incapable of sustaining his axial weight, had not developed fine motor skills or sphincter control, and presented with dysfunctional swallowing and language. Supplementary tests showed low IGF-11 levels, with no changes on the image of the hypothalamus-pituitary region, and bone age consistent with three-year-old children - for a chronological age of six years and one month. Growth hormone replacement therapy had a strong impact on the weight-height recovery as well as on the neurological and psychomotor development of this child.

A resposta estatural ao uso de hormônio do crescimento na baixa estatura já está comprovada na literatura. A influência dos componentes do eixo fator de crescimento semelhante à insulina tipo 1 (GH-IGF1) sobre desenvolvimento, função, regeneração, neuroproteção, cognição e funções motoras tem sido avaliada em estudos experimentais e em adultos com lesão de sistema nervoso central. No entanto, ainda são poucas as pesquisas sobre o impacto clínico da reposição hormonal no desenvolvimento neuropsicomotor. Este relato apresenta o caso de um paciente com excelente recuperação pôndero-estatural e, de forma ainda mais surpreendente, de desenvolvimento neuropsicomotor, em resposta ao uso de hormônio do crescimento. O resultado observado fortalece a correlação entre achados experimentais e clínicos, no que diz respeito à resposta da plasticidade cerebral ao hormônio do crescimento em crianças. Paciente do sexo masculino nasceu pré-termo com múltiplos agravos no período neonatal e de lactente jovem, e que, por 6 anos, apresentou deficit relevante do crescimento, na maturação óssea e do desenvolvimento neuropsicomotor. Aos 6 anos de idade, apresentava baixa estatura (escore Z de −6,89), baixa velocidade de crescimento e baixo peso (escore Z de −7,91). Era incapaz de sustentar o peso axial, não tinha desenvolvido habilidade motora fina e nem controle esfincteriano, e apresentava também disfunção na deglutição e na linguagem. Exames complementares mostraram IGF1 baixo, sem alterações na imagem da região hipotálamo-hipofisária e idade óssea compatível com 3 anos — para a idade cronológica de 6 anos e 1 mês. A terapia de reposição com hormônio do crescimento promoveu forte impacto na recuperação pôndero-estatural e também do desenvolvimento neuropsicomotor desta criança.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Relevant history of hospitalization and…

Figure 1. Relevant history of hospitalization and outpatient care from admission to beginning of endocrinology…

Figure 1. Relevant history of hospitalization and outpatient care from admission to beginning of endocrinology follow-up
Figure 2

Figure 2. Relevant clinical aspects of development,…

Figure 2. Relevant clinical aspects of development, from admission

Figure 2. Relevant clinical aspects of development, from admission
Figure 3

Figure 3. Auxological development and its relation…

Figure 3. Auxological development and its relation with the initiation of hormone replacement. (A) weight…

Figure 3. Auxological development and its relation with the initiation of hormone replacement. (A) weight percentile by age for 2-to-20-year-old boys with cerebral palsy; (B) height percentile by age for 2-to-20-year-old boys with cerebral palsy; (C) height percentile by age for 5-to-19-year-old boys with normal development. As reference for A and B, we used the graphs: Brooks J, Day S, Shavelle R, Strauss D. Low weight, morbidity, and mortality in children with cerebral palsy: new clinical growth charts. Pediatrics. 2011;128(2):e299-307; and for C, those from the: World Health Organization(WHO). WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006. 312 p.
See this image and copyright information in PMC

Similar articles

  • Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data. Reinehr T, Bechtold-Dalla Pozza S, Bettendorf M, Doerr HG, Gohlke B, Hauffa BP, Kaspers S, Land C, Mehls O, Schwab KO, Stahnke N, Ranke MB; German KIGS Study Board. Reinehr T, et al. Exp Clin Endocrinol Diabetes. 2011 Oct;119(9):544-8. doi: 10.1055/s-0031-1285913. Epub 2011 Oct 17. Exp Clin Endocrinol Diabetes. 2011. PMID: 22006181
  • Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment. Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K. Kriström B, et al. J Clin Endocrinol Metab. 1997 Sep;82(9):2889-98. doi: 10.1210/jcem.82.9.4234. J Clin Endocrinol Metab. 1997. PMID: 9284715
  • Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years. Ross JL, Lee PA, Gut R, Germak J. Ross JL, et al. Growth Horm IGF Res. 2015 Dec;25(6):286-93. doi: 10.1016/j.ghir.2015.08.006. Epub 2015 Aug 22. Growth Horm IGF Res. 2015. PMID: 26363846
  • Growth and growth hormone treatment in short stature children born small for gestational age. Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, Longás AF. Labarta JI, et al. Pediatr Endocrinol Rev. 2009 Feb;6 Suppl 3:350-7. Pediatr Endocrinol Rev. 2009. PMID: 19404234 Review.
  • Growth hormone: health considerations beyond height gain. Ross J, Czernichow P, Biller BM, Colao A, Reiter E, Kiess W; advisory panel meeting on the effects of growth hormone. Ross J, et al. Pediatrics. 2010 Apr;125(4):e906-18. doi: 10.1542/peds.2009-1783. Epub 2010 Mar 22. Pediatrics. 2010. PMID: 20308212 Review.
See all similar articles

Cited by

  • Correlation Study between Levels of Gastrin, Serum IGF-1, and GHBP and Growth and Development in Children with Short Stature Based on Big Data Analysis. Hua C, Yu D. Hua C, et al. Dis Markers. 2022 Aug 25;2022:4614099. doi: 10.1155/2022/4614099. eCollection 2022. Dis Markers. 2022. PMID: 36061351 Free PMC article.

References

    1. Brasil. Ministério da Saúde . Saúde da criança: crescimento e desenvolvimento [Internet] Brasília (DF): Ministério da Saúde; 2012. [[citado 2018 Fev 20]]. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. [Cadernos de Atenção Básica, nº 33]. Disponível em: http://189.28.128.100/dab/docs/publicacoes/cadernos_ab/caderno_33.pdf.
    1. Aberg D. Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. Endocr Dev. 2010;17:63–76. Review. - PubMed
    1. Alatzoglou KS, Webb EA, Le Tissier P, Dattani MT. Isolated growth hormone deficiency (GHD) in childhood and adolescence: recent advances. Endocrine Rev. 2014;35(3):376–432. Review. - PubMed
    1. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley DS, CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014;67(1):46–51. - PubMed
    1. Ransome MI, Goldshmit Y, Bartlett PF, Waters MJ, Turnley AM. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur J Neurosci. 2004;19(8):2069–2079. - PubMed
Show all 8 references

Publication types

  • Case Reports Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

MeSH terms

  • Body Height / drug effects Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Body Height / physiology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Body Weight / drug effects Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Body Weight / physiology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Child Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Child Development / drug effects* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Child Development / physiology* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Hormone Replacement Therapy / methods* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Human Growth Hormone / deficiency* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Human Growth Hormone / therapeutic use* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Humans Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Male Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Nervous System Diseases / drug therapy Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Psychomotor Disorders / drug therapy Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Time Factors Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Treatment Outcome Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

Substances

  • Human Growth Hormone Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

LinkOut - more resources

  • Full Text Sources

    • Europe PubMed Central
    • PubMed Central
    • Scientific Electronic Library Online

  • Other Literature Sources

    • scite Smart Citations

  • Medical

    • MedlinePlus Consumer Health Information
    • MedlinePlus Health Information

  • Miscellaneous

    • NCI CPTAC Assay Portal

Từ khóa » Hgh Baixo